Skip to content
10-Q/A

Quarterly Report

CALYPTE BIOMEDICAL CORP

0001437749-11-009085

← back to feed
Filed
Nov 30, 2011 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2011 · Nov 4, 2011 547.83M sh
Shares Diluted Q2 2011 · Jun 30, 2011 547.83M sh
Shares Diluted Q2 2011 · Jun 30, 2011 543.85M sh
Shares Diluted Q2 2011 · Jun 30, 2010 477.34M sh
Shares Diluted Q2 2011 · Jun 30, 2010 471.91M sh
Operating Cash Flow Q2 2011 · Jun 30, 2011 −$81K
Operating Cash Flow Q2 2011 · Jun 30, 2010 −$451K
Cash And Equivalents Q2 2011 · Jun 30, 2011 $175K
Cash And Equivalents Q2 2011 · Dec 31, 2010 $79K
Cash And Equivalents Q2 2011 · Jun 30, 2010 $55K
Cash And Equivalents Q2 2011 · Dec 31, 2009 $176K
Stockholders Equity Q2 2011 · Jun 30, 2011 −$4.61M
Stockholders Equity Q2 2011 · Dec 31, 2010 −$5.09M
Current Liabilities Q2 2011 · Jun 30, 2011 $3.22M
Current Liabilities Q2 2011 · Dec 31, 2010 $3.89M
Total Liabilities Q2 2011 · Jun 30, 2011 $6.81M
Total Liabilities Q2 2011 · Dec 31, 2010 $7.43M
Current Assets Q2 2011 · Jun 30, 2011 $382K
Current Assets Q2 2011 · Dec 31, 2010 $403K
Total Assets Q2 2011 · Jun 30, 2011 $2.2M
Total Assets Q2 2011 · Dec 31, 2010 $2.33M
Sga Expense Q2 2011 · Jun 30, 2011 $205K
Sga Expense Q2 2011 · Jun 30, 2011 $454K
Sga Expense Q2 2011 · Jun 30, 2010 $210K
Sga Expense Q2 2011 · Jun 30, 2010 $486K
Rd Expense Q2 2011 · Jun 30, 2011 $67K
Rd Expense Q2 2011 · Jun 30, 2011 $141K
Rd Expense Q2 2011 · Jun 30, 2010 $36K
Rd Expense Q2 2011 · Jun 30, 2010 $120K
Net Income Q2 2011 · Jun 30, 2011 −$296K
Net Income Q2 2011 · Jun 30, 2011 −$195K
Net Income Q2 2011 · Jun 30, 2010 −$686K
Net Income Q2 2011 · Jun 30, 2010 −$1.23M
Operating Income Q2 2011 · Jun 30, 2011 −$286K
Operating Income Q2 2011 · Jun 30, 2011 −$525K
Operating Income Q2 2011 · Jun 30, 2010 −$227K
Operating Income Q2 2011 · Jun 30, 2010 −$500K
Cost Of Revenue Q2 2011 · Jun 30, 2011 $149K
Cost Of Revenue Q2 2011 · Jun 30, 2011 $328K
Cost Of Revenue Q2 2011 · Jun 30, 2010 $40K
Cost Of Revenue Q2 2011 · Jun 30, 2010 $84K